Kwakkel J, Chassande O, van Beeren H C, Wiersinga W M, Boelen A
Department of Endocrinology and Metabolism, Academic Medical Center University of Amsterdam, F5-165, Meibergdreef 9, 1105 AZ Amsterdam The Netherlands.
J Endocrinol. 2008 Apr;197(1):151-8. doi: 10.1677/JOE-07-0601.
The downregulation of liver deiodinase type 1 (D1) is supposed to be one of the mechanisms behind the decrease in serum tri-iodothyronine (T3) observed during non-thyroidal illness (NTI). Liver D1 mRNA expression is positively regulated by T3, mainly via the thyroid hormone receptor (TR)beta1. One might thus expect that lacking the TRbeta gene would result in diminished downregulation of liver D1 expression and a smaller decrease in serum T3 during illness. In this study, we used TRbeta-/- mice to evaluate the role of TRbeta in lipopolysaccharide (LPS, a bacterial endotoxin)-induced changes in thyroid hormone metabolism. Our results show that the LPS-induced serum T3 and thyroxine and liver D1 decrease takes place despite the absence of TRbeta. Furthermore, we observed basal differences in liver D1 mRNA and activity between TRbeta-/- and wild-type mice and TRbeta-/- males and females, which did not result in differences in serum T3. Serum T3 decreased rapidly after LPS administration, followed by decreased liver D1, indicating that the contribution of liver D1 during NTI may be limited with respect to decreased serum T3 levels. Muscle D2 mRNA did not compensate for the low basal liver D1 observed in TRbeta-/- mice and increased in response to LPS in TRbeta-/- and WT mice. Other (TRbeta independent) mechanisms like decreased thyroidal secretion and decreased binding to thyroid hormone-binding proteins probably play a role in the early decrease in serum T3 observed in this study.
肝脏1型脱碘酶(D1)的下调被认为是非甲状腺疾病(NTI)期间血清三碘甲状腺原氨酸(T3)降低背后的机制之一。肝脏D1 mRNA表达主要通过甲状腺激素受体(TR)β1受T3的正向调节。因此,人们可能会认为缺乏TRβ基因会导致肝脏D1表达下调减弱,以及疾病期间血清T3降低幅度减小。在本研究中,我们使用TRβ基因敲除小鼠来评估TRβ在脂多糖(LPS,一种细菌内毒素)诱导的甲状腺激素代谢变化中的作用。我们的结果表明,尽管缺乏TRβ,LPS诱导的血清T3、甲状腺素和肝脏D1仍会降低。此外,我们观察到TRβ基因敲除小鼠与野生型小鼠之间以及TRβ基因敲除的雄性和雌性小鼠之间,肝脏D1 mRNA和活性存在基础差异,但这并未导致血清T3出现差异。LPS给药后血清T3迅速降低,随后肝脏D1降低,这表明在NTI期间肝脏D1对血清T3水平降低的贡献可能有限。肌肉D2 mRNA并未补偿TRβ基因敲除小鼠中观察到的低基础肝脏D1水平,并且在TRβ基因敲除小鼠和野生型小鼠中,其在LPS刺激下均升高。其他(不依赖TRβ的)机制,如甲状腺分泌减少和与甲状腺激素结合蛋白的结合减少,可能在本研究中观察到的血清T3早期降低中起作用。